IDXX Q4 2019 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$605M+10.2% YoY

Gross Profit

$331M54.7% margin

Operating Income

$116M19.1% margin

Net Income

$90M14.9% margin

EPS (Diluted)

$1.04

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

$155M

Free Cash Flow

$110M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.7B

Stockholders' Equity

$177M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$605M	$549M	+10.2%
Gross Profit	$331M	$300M	+10.3%
Operating Income	$116M	$115M	+0.2%
Net Income	$90M	$86M	+5.7%

Revenue Segments

Instrument Rebate Programs

$4M100%

Geographic Segments

UNITED STATES

$368M69%

Asia Pacific

$129M24%

CANADA

$24M5%

Latin America

$15M3%